High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.

Willemze R;Suciu S;Meloni G;Labar B;Marie JP;Halkes CJ;Muus P;Mistrik M;Amadori S;SPECCHIA, Giorgina;Fabbiano F;Nobile F;Sborgia M;Camera A;Selleslag DL;Lefrère F. Sr;Magro D;Sica S;Cantore N;Beksac M;Berneman Z;Thomas X;Melillo L;Guimaraes JE;Leoni P;Luppi M;Mitra ME;Bron D;Fillet G;Marijt EW;Venditti A;Hagemeijer A;Mancini M;Jansen J;Cilloni D;Meert L;Fazi P;Vignetti M;Trisolini SM;Mandelli F;de Witte T.

2014-01-01